Haemonetics (NYSE:HAE) is planning to spend $20 million on an expansion of a facility in Union, S.C., that will add 40 jobs over the next 5 years.
Braintree, Mass.-based Haemonetics, which makes blood management products, plans to add 3,000 square feet to the Union plant, where it’s had a presence for 20 years, and upgrade its equipment and infrastructure.
“The South Carolina community has been an integral partner in our manufacturing operations for the last 20 years, and our decision to further invest in the Union facility reflects upon the diverse pool of talent, partners and resources that South Carolina has to offer. I look forward to continuing our strategy of continuous improvement and manufacturing excellence in Union, helping to further support our global product lines,” Haemonetics interim CEO Ron Gelbman said in prepared remarks.
“Haemonetics has been doing business in South Carolina for 20 years, and it’s exciting to see this great company make the decision to expand here. This nearly $20 million investment, and the 40 new jobs it will bring to Union County, is a testament to Haemonetics’ commitment to South Carolina, and we look forward to watching its continued success here for many years to come,” added Gov. Nikki Haley (R).
The plant in Union makes products for Haemonetics’ plasmapheresis business.
Earlier this month, the company lowered its outlook for fiscal 2016, saying it expects lower revenues from Russia and Japan and the slow uptake on its HaemoCloud software during the 2nd half of the year. Former CEO Brian Concannon stepped down Sept. 29 to pursue “other opportunities” after 6 years at Haemonetics, replaced on an interim basis by board member Gelbman.
